Company overview
Basic information
Company name
Baltijos biotechnologijos, UAB
Company code
303110825
VAT code
LT100007948316
Registered address
Vilnius, Antano Tumėno g. 4-38, LT-01109
Registration date
2013-07-30
Company age: 13 y. 2 mo.
Contact information
Edit data
Phone
Email
Presented as an image – cannot be copied
Presented as an image – cannot be copied
Website
https://www.bbtechnologijos.lt
Company manager
For registered members only
Log in
Indicators
Risk factors
Activity
Legal form
Private Limited Liability Company
NACE activity
Development of building projects
Ownership form
Private without foreign capital
UAB "Baltijos biotechnologijos"
Company code: 303110825
Address: Vilnius, Antano Tumėno g. 4-38, LT-01109
VAT code: LT100007948316
Download a detailed company report
Make confident decisions with all the information about Baltijos biotechnologijos, UAB. In one document, you will find full financial data, risk and potential assessment, and key Scoris insights.
Description
This description was generated by artificial intelligence.
Baltijos biotechnologijos, UAB (company code 303110825) is an operational private limited liability company registered in 2013. It is classified as a private company in the national private non-financial companies sector, under private ownership, with governance described as CEO only. The company is based in Vilnius, Vilniaus m. sav., Vilniaus apskr., at Antano Tumeno g. 4-38, LT-01109. Its main activity is EVRK code M.68.12.00, Development of building projects.
In financial year 2025, the company generated revenue of €520.1K, up from €366.7K in 2024 and €51.4K in 2023. Despite this growth, it reported a net loss of €284.6K in 2025, after losses of €143.2K in 2024 and €103.1K in 2023. Equity remained negative at €650.9K at the end of 2025, while liabilities stood at €3.30M and total assets at €2.65M. The company’s share capital is €499.4K.
Average employment was 4 in 2025 and 3 so far in 2026. The average monthly wage was €1,428.17 in 2025 and €1,705.35 so far in 2026.
In financial year 2025, the company generated revenue of €520.1K, up from €366.7K in 2024 and €51.4K in 2023. Despite this growth, it reported a net loss of €284.6K in 2025, after losses of €143.2K in 2024 and €103.1K in 2023. Equity remained negative at €650.9K at the end of 2025, while liabilities stood at €3.30M and total assets at €2.65M. The company’s share capital is €499.4K.
Average employment was 4 in 2025 and 3 so far in 2026. The average monthly wage was €1,428.17 in 2025 and €1,705.35 so far in 2026.